Literature DB >> 6757308

Significance of atretic follicles as the site of androgen production in polycystic ovaries.

T Mori, Y Fujita, K Nihnobu, T Aso, Y Sakamoto, T Nishimura.   

Abstract

To examine androgenic potential of polycystic ovaries (PCO), slices of follicular and stromal tissues from the same ovary obtained by wedge resection from two markedly, two moderately and one slightly enlarged PCO were incubated separately with [1-14C] acetate. Incorporation into progestins, androgens and estrogens was assessed by reverse dilution technique with recrystallization to constant specific activity. Although the greatest incorporation into androstenedione with much lesser incorporation into testosterone and dehydroepiandrosterone was observed with all the five follicles, the amount of incorporation into the three steroids increased gradedly with histologically defined magnitude of thecal cell hyperplasia in atretic follicles. Only the stromal tissues from two markedly enlarged PCO produced androgens with a similar pattern of 14C distribution among the steroids, thereby incorporation into the three androgens remaining 5.5% or less of that by the follicles from the same ovary. Preoperative levels of plasma androstenedione and urinary 17-ketosteroids were shown to increase in four patients with PCO containing atretic follicles with thecal cell hyperplasia, but not in one patient with slightly enlarged PCO containing atretic follicles without thecal cell hyperplasia. It is inferred that atretic follicles with thecal cell hyperplasia is a significant source of androgen overproduction by PCO.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6757308     DOI: 10.1007/BF03348325

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  17 in total

Review 1.  GONADOTROPINS AND OVARIAN STEROIDOGENESIS.

Authors:  K SAVARD; J M MARSH; B F RICE
Journal:  Recent Prog Horm Res       Date:  1965

2.  Further observations on the defective synthesis of ovarian steroids in the Stein-Leventhal syndrome.

Authors:  R V SHORT
Journal:  J Endocrinol       Date:  1962-06       Impact factor: 4.286

3.  The ovarian theca cell. IV. The hyperthecosis syndrome.

Authors:  S SHIPPEL
Journal:  J Obstet Gynaecol Br Emp       Date:  1955-06

4.  Familial hyperthecosis: comparison of endocrinologic and histologic findings with polycystic ovarian disease.

Authors:  H L Judd; R E Scully; A L Herbst; S S Yen; F M Ingersol; B Kliman
Journal:  Am J Obstet Gynecol       Date:  1973-12-01       Impact factor: 8.661

5.  Steroid formation by isolated and recombined ovarian granulosa and tehcal cells.

Authors:  K J Ryan; Z Petro; J Kaiser
Journal:  J Clin Endocrinol Metab       Date:  1968-03       Impact factor: 5.958

Review 6.  The polycystic ovary syndrome.

Authors:  S S Yen
Journal:  Clin Endocrinol (Oxf)       Date:  1980-02       Impact factor: 3.478

7.  Testosterone and androstenedione blood production rates in normal women and women with idiopathic hirsutism or polycystic ovaries.

Authors:  C W Bardin; M B Lipsett
Journal:  J Clin Invest       Date:  1967-05       Impact factor: 14.808

8.  Steroidogenesis in vitro by human ovarian follicles during the process of atresia.

Authors:  T Mori; Y Fujita; K Nihnobu; Y Bzaki; K Kubo; T Nishimura
Journal:  Clin Endocrinol (Oxf)       Date:  1982-04       Impact factor: 3.478

9.  The intraovarian sites of androgen and estrogen formation in women with normal and hyperandrogenic ovaries as judged by in vitro experiments.

Authors:  K P McNatty; D M Smith; A Makris; C DeGrazia; D Tulchinsky; R Osathanondh; I Schiff; K J Ryan
Journal:  J Clin Endocrinol Metab       Date:  1980-04       Impact factor: 5.958

10.  Steroid hormone formation in human ovarian follicles in vitro.

Authors:  T Mori
Journal:  Endocrinol Jpn       Date:  1976-10
View more
  1 in total

1.  The effect of laparoscopic treatment of polycystic ovarian disease by CO2-laser or Nd:YAG laser.

Authors:  G Keckstein; W Rossmanith; K Spatzier; V Schneider; K Börchers; R Steiner
Journal:  Surg Endosc       Date:  1990       Impact factor: 4.584

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.